From July 1, 2022 to September 30, 2022, the company has repurchased 259,353 shares, representing 0.04% for CNY 1.47 million. With this, the company has completed the repurchase of 3,879,353 shares, representing 0.54% for CNY 28.77 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 CNY | -0.42% | -4.27% | -14.83% |
1st Jan change | Capi. | |
---|---|---|
-14.83% | 457M | |
+19.07% | 43.46B | |
+24.43% | 22.61B | |
+16.41% | 15.15B | |
+22.68% | 14.83B | |
+57.41% | 13.08B | |
-0.05% | 6.79B | |
-12.44% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.